bmiMD Reviews
Compounded GLP-1 weight-loss care, prescribed online and shipped cold-chain
Last updated: Sep 10, 2026
Reviewed for medical accuracy by Francheska Capistrano, RMT, MPH · · How we review
Reviewed for medical accuracy by Francheska Capistrano, RMT, MPH · Medical Content Reviewer
Medically reviewed Reviewed · Written by Treatments Hub Research Team · How we review
We may earn a commission from links on this page - it never affects our rankings (how we stay objective).
The bottom line
bmiMD is a credible, well-reviewed telehealth GLP-1 provider: its 4.4 Trustpilot average across 870 reviews is a real, high-volume track record, and the recurring praise for responsive support and carefully cold-packed shipping matches what you want from an online pharmacy handling temperature-sensitive medication. The honest caveats are that the $149 and $159 3-month prices are shown as limited-time rates, we haven't captured the prices of longer plans, and support runs through messaging.
If you want an established provider with a broad treatment menu and dependable delivery, bmiMD is worth a look - confirm the current plan pricing on its site before you commit.
bmiMD is a New York-based telehealth company offering compounded GLP-1 weight-loss treatment - semaglutide and tirzepatide, including microdose versions - prescribed online and shipped to your door in most US states. It carries a solid track record: 4.4 on Trustpilot across 870 reviews, where the recurring themes are responsive customer service and reliable, properly cold-packed delivery.
"Medication works as it should. Always delivered on time and packaged properly with cold packs," writes one recent reviewer; another reports going "from 238 to 213 in 3 weeks."
The flow is the standard cash-pay one - an online medical intake reviewed by a licensed provider, with a money-back guarantee if you're not approved. Two honest notes before the details: the prices we have verified are bmiMD's 3-month plan rates ($149/month for semaglutide, $159/month for tirzepatide, shown as a limited-time price on November 3, 2026), so confirm the cost of longer plans on its site, and support is handled through messaging rather than a phone line.
Customer review summary
bmiMD holds a 4.4 out of 5 across 870 reviews on its claimed Trustpilot profile (as shown on Sep 2026; view the profile). Of the 6 reviews we transcribed verbatim (reviews dated Jul 2, 2026 to Jul 23, 2026), 6 5-star: 100% rate it 4 or 5 stars and 0% rate it 1 or 2 stars. How we collect customer reviews
Key Features
- Compounded semaglutide and tirzepatide, plus microdose options
- Prescribed online by a licensed provider; ships to ~49 states
- Cold-chain delivery to your door
- 4.4 Trustpilot average across 870 reviews
- Money-back guarantee if you're not approved
Treatment Options
- Compounded semaglutide (GLP-1) injection
- Compounded tirzepatide (GLP-1 + GIP) injection
- Microdose versions of each
- Additional weight-related options (e.g. metformin, MIC + B12)
Pricing
bmiMD offers its compounded GLP-1 medications on subscription plans. On the 3-month plan, shown as a limited-time price when we verified it on November 3, 2026, compounded semaglutide is $149/month ($447 for 3 months) and compounded tirzepatide is $159/month ($477 for 3 months), the same price at every dose, with free shipping on subscription orders and a full refund if you're not eligible. bmiMD also offers 12-month, 6-month and 1-month plans; we did not capture those plans' prices, so confirm them on bmiMD's site before signing up.
Pros
- Strong, high-volume Trustpilot record (4.4 across 870 reviews)
- Responsive customer service is the most consistent praise in reviews
- Reliable cold-chain shipping
- Broad treatment menu, including microdose options
- Money-back guarantee if you're not approved
Cons
- Verified pricing covers the 3-month plan only, at a limited-time rate; longer plans' prices weren't captured
- Support is message-based rather than a phone line
Who It's Best For
- People who want an established provider with a broad GLP-1 menu
- Anyone who values responsive support and dependable delivery
Final Verdict
bmiMD is a credible, well-reviewed telehealth GLP-1 provider: its 4.4 Trustpilot average across 870 reviews is a real, high-volume track record, and the recurring praise for responsive support and carefully cold-packed shipping matches what you want from an online pharmacy handling temperature-sensitive medication. The honest caveats are that the $149 and $159 3-month prices are shown as limited-time rates, we haven't captured the prices of longer plans, and support runs through messaging.
If you want an established provider with a broad treatment menu and dependable delivery, bmiMD is worth a look - confirm the current plan pricing on its site before you commit.
bmiMD Review: FAQs
Is bmiMD legit?
bmiMD is a New York-based telehealth company offering compounded GLP-1 weight-loss treatment - semaglutide and tirzepatide, including microdose versions - prescribed online and shipped to your door in most US states. It carries a solid track record: 4.4 on Trustpilot across 870 reviews, where the recurring themes are responsive customer service and reliable, properly cold-packed delivery. "Medication works as it should. Always delivered on time and packaged properly with cold packs," writes one recent reviewer; another reports going "from 238 to 213 in 3 weeks." The flow is the standard cash-pay one - an online medical intake reviewed by a licensed provider, with a money-back guarantee if you're not approved. Two honest notes before the details: the prices we have verified are bmiMD's 3-month plan rates ($149/month for semaglutide, $159/month for tirzepatide, shown as a limited-time price on November 3, 2026), so confirm the cost of longer plans on its site, and support is handled through messaging rather than a phone line.
How much does bmiMD cost?
bmiMD offers its compounded GLP-1 medications on subscription plans. On the 3-month plan, shown as a limited-time price when we verified it on November 3, 2026, compounded semaglutide is $149/month ($447 for 3 months) and compounded tirzepatide is $159/month ($477 for 3 months), the same price at every dose, with free shipping on subscription orders and a full refund if you're not eligible. bmiMD also offers 12-month, 6-month and 1-month plans; we did not capture those plans' prices, so confirm them on bmiMD's site before signing up.
What treatments does bmiMD offer?
bmiMD offers Compounded semaglutide (GLP-1) injection, Compounded tirzepatide (GLP-1 + GIP) injection, Microdose versions of each, Additional weight-related options (e.g. metformin, MIC + B12).
Who is bmiMD best for?
bmiMD is best for People who want an established provider with a broad GLP-1 menu; Anyone who values responsive support and dependable delivery.
Is bmiMD worth it?
bmiMD is a credible, well-reviewed telehealth GLP-1 provider: its 4.4 Trustpilot average across 870 reviews is a real, high-volume track record, and the recurring praise for responsive support and carefully cold-packed shipping matches what you want from an online pharmacy handling temperature-sensitive medication. The honest caveats are that the $149 and $159 3-month prices are shown as limited-time rates, we haven't captured the prices of longer plans, and support runs through messaging. If you want an established provider with a broad treatment menu and dependable delivery, bmiMD is worth a look - confirm the current plan pricing on its site before you commit.
Not sure if bmiMD is right for you?
Take our free quiz and get a personalized provider recommendation.
Find Your MatchRelated
Guides
Sources & methodology
We built this review of bmiMD from the provider'sown published pricing, plans and policies, cross-checked against regulatory and peer-reviewed medical references, and read alongside real customer feedback. Prices and plan details were verified against the provider's published information; we do not take providers' word for their own claims without checking.
Provider information
Pricing, plans, shipping and policies, checked against each provider's own site.
- bmiMD - pricing, plans & policies as published on its own site
Provider data checked September 2026
Customer & community feedback
Third-party signals shown on this page and in our full reviews: verified Trustpilot ratings, public Reddit discussions, and independent YouTube reviews. We report what these sources say - we never fold their ratings into our own scores.
Medical & regulatory references
- 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
- 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
- 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
- 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
- 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
- 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
- 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)
Last reviewed September 2026. We revisit comparisons when providers change their pricing or policies. This page is information only and is not medical advice - always consult a licensed clinician before starting treatment.
Medical disclaimer
This page is general information about GLP-1 weight-loss medications such as semaglutide and tirzepatide, published to help you compare services. It is not medical advice, it does not create a doctor-patient relationship, and it is not a substitute for a consultation with a licensed clinician who knows your history. Treatments Hub is not a medical provider, pharmacy or clinic and does not prescribe, sell or dispense medication. Do not start, stop or change any treatment because of something you read here, and do not delay seeking care; in an emergency call 911.
Semaglutide and tirzepatide carry an FDA boxed warning about thyroid C-cell tumours seen in rodents and are not for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, nor for use in pregnancy. Compounded versions sold by telehealth providers are prepared by state-licensed pharmacies and are not FDA-approved products. Where a review or post on this page mentions weight lost, that is one person's result and is not typical; results vary widely.
Medical and scientific statements on this site are checked against the sources linked on the page by our medical content reviewer, who does not choose providers or set prices. Prices, plans and customer reviews are each provider's published figures and customers' own words on the dates stated. We may earn a commission from provider links. The full medical and advertising disclaimer explains all of this in detail.
Sources & medical references
Treatment facts on this page are grounded in regulatory guidance and peer-reviewed research. Pricing and plan details come from each provider's published information. This content is for information only and is not medical advice - always consult a licensed clinician before starting treatment.
- 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
- 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
- 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
- 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
- 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
- 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
- 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)